These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8213633)

  • 1. Pattern of expression of CD45 RA/RO isoformic antigens in acute myeloblastic leukemia cells.
    Kawano S; Tatsumi E; Yoneda N; Yamaguchi N
    Am J Clin Pathol; 1993 Oct; 100(4):386-93. PubMed ID: 8213633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression pattern of CD45 RA/RO isoformic antigens in T-lineage neoplasms.
    Kawano S; Tatsumi E; Yoneda N; Tani A; Nakamura F
    Am J Hematol; 1995 May; 49(1):6-14. PubMed ID: 7741140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytokine in phenotypic analysis of leukemia/lymphoma: suppression of gene expression of myeloperoxidase by IFN-gamma and subset of AML M1 defined by CD45RO+/RA-, CD7(-), CD34(-) and non-inducible HLA-DR antigen].
    Tatsumi E; Yoneda N; Kawano S; Yamaguchi N
    Rinsho Byori; 1993 Apr; 41(4):377-83. PubMed ID: 7688832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of CD45 isoforms in differentiation of acute myeloid leukemia.
    Miyachi H; Tanaka Y; Gondo K; Kawada T; Kato S; Sasao T; Hotta T; Oshima S; Ando Y
    Am J Hematol; 1999 Nov; 62(3):159-64. PubMed ID: 10539882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of CD64, other monocyte-associated antigens, and CD45 gating in the subclassification of acute myeloid leukemias with monocytic differentiation.
    Krasinskas AM; Wasik MA; Kamoun M; Schretzenmair R; Moore J; Salhany KE
    Am J Clin Pathol; 1998 Dec; 110(6):797-805. PubMed ID: 9844593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Loss of CD45 expression at relapse of acute myeloid leukemia].
    Yamamoto K; Yakushijin K; Kurata K; Mizutani Y; Inui Y; Uryu K; Kawamoto S; Sugimoto T; Matsuoka H; Minami H
    Rinsho Ketsueki; 2017; 58(8):938-941. PubMed ID: 28883278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F; Chen Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G; Stasi R; Venditti A; Suppo G; Aronica G; Bruno A; Masi M; Tabilio A; Papa G
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
    Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
    Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
    Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
    Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
    Mesárosová A; Hrivnáková A; Babusíková O
    Neoplasma; 1993; 40(6):341-5. PubMed ID: 8289964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
    Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
    Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical analysis of HLA-DR-negative non-M3 AML].
    Mori H; Sakai H; Sanada M; Shimamoto K; Sasaki S; Azuma R; Higuchi T; Harada H; Niikura H; Omine M; Fujita K; Takahashi N
    Rinsho Ketsueki; 2007 Jul; 48(7):547-53. PubMed ID: 17695303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of membrane CD45 isoform expression by leukaemic blasts and normal mature myeloid cells.
    Master PS; Richards SJ; Roberts BE; Scott CS
    Int J Hematol; 1992 Jun; 55(3):235-42. PubMed ID: 1386761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-G expression is irrelevant to prognosis in patients with acute myeloid leukemia.
    Guo QY; Chen BG; Ruan YY; Lin A; Yan WH
    Leuk Res; 2011 Oct; 35(10):1350-4. PubMed ID: 21696824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia.
    Griffin JD; Davis R; Nelson DA; Davey FR; Mayer RJ; Schiffer C; McIntyre OR; Bloomfield CD
    Blood; 1986 Dec; 68(6):1232-41. PubMed ID: 2946331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting antigenic maturation patterns in M0-M2 versus M3 acute myeloid leukemias.
    Lewis RE; Cruse JM; Webb RN; Sanders CM; Beason K
    Exp Mol Pathol; 2007 Oct; 83(2):269-73. PubMed ID: 17603036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the leucocyte common antigen (LCA, CD45) isoforms RA and RO in acute haematological malignancies: possible relevance in the definition of new overlap points between normal and leukaemic haemopoiesis.
    Schiavone EM; Lo Pardo C; Di Noto R; Manzo C; Ferrara F; Vacca C; Del Vecchio L
    Br J Haematol; 1995 Dec; 91(4):899-906. PubMed ID: 8547136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.